Quadessy delivers multi-layer skin remodeling through a unique tip and dual-depth design
A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.
We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.
We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.
Definition medical devices.
Quadessy delivers multi-layer skin remodeling through a unique tip and dual-depth design
Medtronic's latest partnership with Merit Medical Systems introduces the groundbreaking ViaVerte™ BVNA system—an innovative solution for chronic vertebrogenic pain
Led by researchers at the Vanderbilt University Medical Center, a new study reports that Optellum's FDA-cleared Lung Cancer Prediction (LCP) AI assisted risk stratification for indeterminate lung nodules is cost-effective from a US payer perspective. Optellum's LCP AI supports more consistent long nodule management and helps enable earlier diagnosis of...
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD
The study, published in The March 2026 edition of Federal Practitioner, reported an association between thermal therapy use and reduced opioid and benzodiazepine utilization, as well as lower healthcare utilization in the patient population.
The Journal of the American Medical Association (JAMA Neurology) publication highlights consistent clinical and biomarker findings from NeuroSense PARADIGM Phase 2b trial in ALS, including slower functional decline, reduced risk of ALS-related complications, and modulation of disease-relevant biomarkers
Joint initiative with Rosebud Biosciences, Kantify, and funded by Incite will identify and quantify off-target toxicities in chemotherapy patients
Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases
Redipor® Legionella agar plate range - specifically designed to support the detection and enumeration of Legionella in water samples
Under the agreement, NAMSA will acquire WuXi AppTec facilities in Minnesota and Georgia.
The round was led by existing investor Mountain Group Partners, with continued support from Brad Whitmore and additional existing investors
This IPO and capital raise mark an important moment for Saluda,” said Barry Regan, President & CEO of Saluda Medical.

You may be surprised to learn the role that your gut health plays in the health of your joints. Remember, your gut is the home to thousands of microorganisms that play a role in your digestion, immunity, and overall health. When your gut microbiome is unbalanced, it can cause inflammation throughout your body, including in your joints, which is why eating healthy is vital for anyone living with chronic joint pain.

‘Closing the Loop: Why a Test Alone isn’t enough’ is about how diagnostics is the gateway to precision Medicine. But what happens before and after the test? In a healthcare system made up of multiple initiatives and institutions, working in siloes, even the most advanced insights can fail to reach their potential.
This article includes a Real-World Example: At-Home Cardiovascular Risk Screening. Take cardiovascular disease a leading cause of death in both the US and UK. In traditional systems, screening often relies on in-person visits that many people never make, particularly amongst the most socially deprived groups.

Rethinking an Overlooked Corner of GI Care / Where Innovation Stalled and Why It Matters
“Receiving the Fast Track Designation for AJ201 marks a significant milestone for AnnJi,” said Dr. Wendy Huang, CEO and Chairperson of the Board of AnnJi.
Neurocritical algorithm to support emergency patient triage added to growing roster of early detection and management solutions
Nathan brings decades of experience in computational and AI-driven discovery. He joins Optibrium from Healx, where, as Director of Digital Chemistry, he led the development of AI-powered computational methods for rare disease drug discovery.
Experienced leader in preclinical and clinical drug development will support expansion of Company’s therapeutics pipeline for complex and common genetic diseases
“Capstan’s platform is tackling an unserved area of cardiovascular care for a patient population that has almost no other options,” said Mohr. “It has the potential to transform heart valve disease for patients at high risk for surgery, into a precise, and low-stress procedure for both patients and clinicians.”
“Arienta is dedicated to expanding access to lifesaving cardiovascular imaging, and we are excited to extend our partnership with the Catalyst team to accelerate that vision” said Doug Ryan, CEO of Arienta.

As the first-ever robotic-driven LigaSure™ instrument, this milestone represents the beginning of a new era for the vessel-sealing technology that has been used in more than 35 million procedures across 65+ countries over the last two decades.

This milestone marks a powerful collaboration between Catalyst MedTech and OncoVision, reinforcing our shared commitment to expanding access to advanced neurologic imaging across the U.S.
Patients in the hospital for surgeries had better outcomes in 2024 than they did in 2019, according to a new report released today by the American Hospital Association and Vizient®

The addition of this cutting-edge technology reinforces the hospital’s commitment to offering patients the highest level of surgical precision and minimally invasive care.
Led by NYU Langone Health Department of Orthopedic Surgery researchers, the study included training a computer system to help analyze animal cells damaged by increasing concentrations of chemicals over time to replicate human aging.

Malpractice insurance plays a key role in a thriving naturopathic practice. It guards your money, protects your name, and gives you and your patients peace of mind.

By managing mental clutter, leveraging technology wisely, creating a supportive environment, and practicing active listening, practitioners can overcome common distractions and remain deeply engaged

Legionella remains one of the most persistent and serious risks in building water systems. Despite advances in water treatment technology, outbreaks continue to occur in settings ranging from hospitals to hotels.
Primarily engineered for precision, the Toomey syringe features a robust barrel with a distinctive tapered tip that allows for controlled delivery of fluids, whether they be medications, anesthetics, or other solutions.
Medical Device News Magazine uses cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
You can find more information in our Cookie Policy: Medical Device NewsMagazine and PRIVACY.